Description: Implementation of Statement of Position 03-1 for Lapse Protected Life Products

Description: A discussion of the use of stochastic modeling in Embedded Value financial reporting

Description: A discussion of areas of AAT where the Actuary uses a considerable degree of discretion and judgment and guidance is limited.

Description: Discussions of alternative approaching to setting ascribed premiums for market risk benefits under FASB targeted improvements.

Description: Panelists discuss the background and history behind NAIC Guideline 33, including changes from the original AG 33 to the new one. Also included are numerical and graphical examples to illustrate the intent of the new Guideline 33. From the 1997 Record of Society of Actuaries, Vol. 23, No. 3.

Description: From the 1985 Valuation Actuary Symposium A review of the process involved in making an actuarial opinion and in developing the related actuarial report to management. This was accomplished through a case study approach, specifically covering a universal life product.

Description: From a session at the 2000 Valuation Actuary Symposium held in Washington DC, September 14-15, 2000 In this session the panelists discussed the issues related to the actuarial aspects associated with the demutualization process. The issues discussed included: • Developing historical and prospective assumptions • Aligning the models used in the company’s philosophy regarding dividend determination and pricing • Creating experience assumptions when less-than-perfect data exist • Determining who gets what • Complying with actuarial and accounting standards

Description: From a session at the 2002 Valuation Actuary Symposium, held in Lake Buena Vista, Florida, September 19–20, 2002 Discussion of issues and the impact of current statutory valuation requirements for life insurance policies. Requirements covered include the Actuarial Standard of Practice on XXX, Actuarial Guideline AXXX, and Actuarial Guidelines 36 and 37. Products and issues discussed include nonlevel premium or nonlevel benefit insurance e.g., selective term, universal life with secondary guarantees or shadow accounts, determination of X factors, interpretation issues regarding XXX, variable life, and variable universal life, equity-indexed universal life, and the new CSO mortality table.

Description: Discusses revenue accounting, use of budgets, automating annual statement work, and reserve calculations for interim statements.

Description: This panel discussion session explored alternative methods for accounting recognition of the costs of policyholder dividends. The theoretical bases, as well as the impact on anticipated earnings patterns, are discussed. Implementation issues are also discussed. Discussion of participating products in the UK and accounting methods used for them is also included.